HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype–phenotype association study
Qian Zhang, Eathar Shakweh, Mohmmed Tauseef Sharip, Benjamin Zaré et autres
3 citationsThe Lancet. Gastroenterology & hepatology
Christopher Roberts
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
34Publications signalées
295Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Inflammatory Bowel DiseaseMicroscopic ColitisHealth Systems, Economic Evaluations, Quality of LifeAcute Lymphoblastic Leukemia researchBiosimilars and Bioanalytical Methods
Publications récentes
Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use
Phoebe Hodges, Christopher Roberts, Miles Parkes, Nicholas A Kennedy et autres
3 citationsJournal of Crohn s and Colitis
HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease
Qian Zhang, Mohammed Sharip, Christopher Roberts, Eathar Shakweh et autres
3 citationsJournal of Crohn s and Colitis
Qualitative Exploration of Barriers and Facilitators to Physical Activity and Exercise in Children and Adolescents With Crohn’s—Perspectives of Young People, Caregivers, and Clinicians
Zoe L. Saynor, Nadeem Afzal, Christopher Roberts, Kelly A. Mackintosh et autres
0 citationsPediatric Exercise Science
Editorial: LAMP Lights the Way—A Pragmatic Case for NUDT15 Screening Across Diverse Populations—Authors' Reply
Christopher Roberts, James Goodhand, Tariq Ahmad
0 citationsAlimentary Pharmacology & Therapeutics
Clinical Utility and Cost‐Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine‐Induced Myelosuppression: A Genotype‐First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource
Christopher Roberts, Jaime Peters, Aleksejs Sazonvos, Neil F. Goodman et autres
7 citationsAlimentary Pharmacology & Therapeutics
P10 Cost-effectiveness of NUDT15 genotype testing to inform thiopurine treatment in inflammatory bowel disease
Christopher Roberts, Jaime Peters, Rebecca Smith, Maria Bishara et autres
0 citations
Tu1889: REAL-WORLD EFFECTIVENESS OF RISANKIZUMAB IN CROHN’S DISEASE: THE UK EXPERIENCE
Alexander T. Elford, Nikolas Plevris, Nathan Constantine‐Cooke, Magdalini Manti et autres
0 citationsGastroenterology
P1037 Prevalence and factors associated with obesity in patients with IBD treated with infliximab and vedolizumab across the United Kingdom (UK)
Christopher Roberts, Paul J. Hodges, Fakhirah Badrulhisham, Rebecca Smith et autres
0 citationsJournal of Crohn s and Colitis
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study within the UK NIHR Inflammatory Bowel Disease Bioresource
Christopher Roberts, Jaime Peters, Aleksejs Sazonovs, Neil F. Goodman et autres
0 citationsSSRN Electronic Journal
OC4 Understanding anti-TNF treatment failure in Crohn’s disease: mechanisms and management of loss of response to anti-TNF therapy, three-year data from the PANTS study
Neil Chanchlani, Simeng Lin, Claire Bewshea, Benjamin Hamilton et autres
1 citationAbstracts
Cross-sectional evaluation of online direct-to-public calprotectin testing
Maria Bishara, Rebecca G. Smith, Christopher Roberts, Yousra Djouider et autres
0 citationsFrontline Gastroenterology
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.